Navigation Links
Kellogg Company Supports China Earthquake Relief Efforts
Date:5/23/2008

BATTLE CREEK, Mich., May 23 /PRNewswire/ -- Kellogg Company today announced a $250,000 donation to the American Red Cross to assist with earthquake relief efforts in the Sichuan province in southwestern China. The contribution is being made by Kellogg's Corporate Citizenship Fund and will be designated to support the efforts of the Red Cross Society of China.

"There is a lot of work ahead as people mobilize to rebuild their lives and communities," said Hans Shin, president, Kellogg Asia. "Our organization is pleased to support these efforts with both monetary and food donations."

With 2007 sales of nearly $12 billion, Kellogg Company (NYSE: K) is the world's leading producer of cereal and a leading producer of convenience foods, including cookies, crackers, toaster pastries, cereal bars, frozen waffles, and meat alternatives. Kellogg products are manufactured in 18 countries and marketed in more than 180 countries around the world. For more information, visit the Kellogg Company web site at http://www.kelloggcompany.com .


'/>"/>
SOURCE Kellogg Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Kellogg School of Management Expert Finds Multicultural Experience Enhances Creativity
2. AUDIO from Medialink and Kelloggs: A Blissful Way to Recommit to Your Resolution
3. AUDIO from Medialink and Kelloggs: A Healthy Beginning Every Day
4. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
5. AUDIO from Medialink and Kelloggs: Ten Delicious Days to Better Digestive Health
6. AUDIO from Medialink and Kellogg: Ten Delicious Days to Better Digestive Health
7. AUDIO from Medialink and Kelloggs: Morning Indulgence Without Guilt
8. Kellogg School of Management Announces Code Red
9. AUDIO from Medialink and Kelloggs: The Jeans Dont Lie
10. AUDIO from Medialink and Kelloggs: Whats in Your Water?
11. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...UNTY, Calif., Nov. 21 Album Creati...irm, launches a new program offering big brand mar...aken the large, expensive ad agency process and se... a very hands-on approach," says Matt Parker, Crea... combines experience and proven brand-building tec...
(Date:11/21/2008)...eeting of shareholders to be held on January 8, 20...ll/ - Med-Emerg International Inc. ("MedEmerg") (O...health services, announced today that it has obtai...rt of Justice concerning its previously announced ...o which AIM Health Group Inc. ("AIM") will acquire...
(Date:11/21/2008)...G, Pa., Nov. 21 During...nor Edward G. Rendell today remembered Lieutenant ...er, an important partner in public service, and a ..., , "As the first woman elected lieutenant ... servant," said Governor Rendell. "Her family and ...
(Date:11/21/2008)..., Va., Nov. 21 The Gene...e following statement today from,GPhA President a... Commission,(FTC) roundtable on "Emerging Health ...he mere fact that the FTC is conducting this round...suring that consumers have access to safe and,aff...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...rs have pledged to identify children at risk in ho...ancy stage itself. // Minister Jack McConnell unve...rm - Next Steps to protect such children effective... to improve the identification of these children a...
...iament Wednesday approved a bill prohibiting smoki...hibits smoking in public groups, restaurants and e...f $12.5. It also restricts selling of cigarettes ... 18. Under the bill, an offender will have to pay ...
...ts major Female Health Company (FHC) has received ...le condoms //for India's state-run National AIDS C...sed in NACO's reproductive health and HIV/AIDS pre...ll initially be focused on commercial sex workers ...
...pointed out the alarming incidence of metabolic sy... official statistics, more than 25 million people,...ion face a high risk of heart attack and stroke. ...vernment health officials have stressed the need f...
Other Medicine News:Health News:US Firm To Supply Female Condoms To India 2
(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)..., Nov. 19 Biotech scientists incre...cology research to better understand the effects o...ems, reports Genetic Engineering & Biotechnol...in figuring out a new compound,s mechanism of acti...gy technique, according to the November 15 issue o...
(Date:11/18/2008)...9 NeuroDiscovery Ltd (AS...r and drug development Company,and Sosei Group C...eading,international biopharmaceutical company, t...urther pivotal pre-clinical efficacy data for NSL-...al therapy for neuropathic pain and has,successfu...
(Date:11/18/2008)...v. 18 Forty-two leading...vember national forum to consider cutting-edge inn...nd national economy from outbreaks of dangerous zo..., , Among those innovations: , , , ...tchen table that detects highly contagious and dan...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 1Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 1New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 3Researchers discover natural herbicide released by grass 1144 1Researchers discover natural herbicide released by grass 1144 2Educational media workshop unites cancer scientists and journalists 5857 1
...st clinical study of,HGS-ETR1 -, ROCKVILLE, Md., A...me Sciences, Inc. today reported that clinical and...ating that its TRAIL receptor,antibodies, HGS-ETR1...gnificant potential for use in the treatment of a ...1 and HGS-ETR2 could offer novel, highly,targeted ...
... - Insmed Inc.,(Nasdaq:INSM) today announced posi...d clinical study of the company,s drug,IPLEX(TM) i...ed,Adipose Redistribution Syndrome (HARS)., Prelim...he,University of California, San Francisco, showed...t in seven patients increased IGF-I,levels 3-fold ...
Other Medicine Technology:Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: